Trials / Recruiting
RecruitingNCT07307586
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
A Small Prospective Clinical Study on Azvudine Tablets for Treating Chronic Hepatitis B.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Zhigang Ren · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Through regular monitoring of viral load, liver function and immune cell activity, the long-term efficacy of Adefovir in controlling HBV is precisely evaluated. By employing a dual mechanism of "antiviral action plus immune activation", it offers a novel therapeutic option for achieving clinical cure in chronic hepatitis B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZVUDINE | CHB patients with Azvudine treatment |
| DRUG | TAF | CHB patients with TAF treatment |
| DRUG | IFNα-2a | CHB patients with IFNα-2a treatment |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2025-12-29
- Last updated
- 2025-12-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07307586. Inclusion in this directory is not an endorsement.